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The primary aim of this study was to evaluate the feasibility and acceptability of 
using mobile applications (apps) designed to ameliorate depressive symptoms in primary 
care. The secondary aim was to examine whether participants utilizing a mobile app 
would experience reductions in depressive symptoms and improvements in quality of 
life.   Recruitment was conducted in two primary care practices. Participants who agreed 
to be part of the trial completed measures of depressive symptoms and quality of life at 
baseline, post-treatment, and a one-month follow-up. Measures of acceptability and 
feasibility were also gathered throughout the study duration. Results provided partial 
support for the feasibility of conducting such a trial on a larger scale. However, specific 
difficulties in recruitment were noted that warrant correction in additional trials. On the 
other hand, individuals who did use the apps were retained across the study duration, 
reported a reduction of depressive symptoms at post-intervention, and found the 
intervention acceptable. Additionally, improvements in certain areas of quality of life, 
such as energy level, fatigue, and emotional well-being at post-intervention were also 
reported. Together, the results provide preliminary evidence in support of the 
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 Primary care has become the first point of contact for a majority of individuals 
experiencing depressive symptoms (Kessler & Stafford, 2008). It is estimated that 5 to 
13% of patients seen by primary care providers are diagnosed with major depressive 
disorder, while the 12-month prevalence of depressive symptoms in primary care is 
12.5% (Mitchell et al., 2009; Pignone et al., 2002). According to Moussavi et al. (2007), 
individuals with a history of depression endorse lower scores on measures of overall 
health when compared to those diagnosed with cardiovascular disease, asthma, arthritis, 
or diabetes. Further, symptoms of depression not only impact an individual's functionality 
in terms of missed work and reduced productivity (Wang et al., 2004), but those 
diagnosed with depression are more likely to report poorer overall physical health and 
experience higher rates of comorbid chronic diseases (Katon, 2003; Kessler & Stafford, 
2008). As a result, individuals diagnosed with depression utilize a significantly greater 
amount of healthcare services and emergency room visits when compared to 
nondepressed individuals (Kessler & Stafford, 2008). Of the $201 billion spent on mental 
health disorders in 2013, $98.9 billion were spent on treating major depressive disorder 
(MDD) alone (Greenberg et al., 2015). 
The standard of care for treating depression within primary care typically involves 
prescribing antidepressant medication, referral for outpatient psychotherapy, or some 
combination of these two treatments (Trangle et al., 2016). However, many patients do 
not adhere to treatment recommendations, discontinue treatment prematurely, or do not 
respond to antidepressants or psychotherapy (Kessler & Stafford, 2008; Sansone & 
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Sansone, 2012; Trangle et al., 2016). Additionally, these treatments may be too intensive 
for individuals with less severe depressive symptomatology. Given the problems 
associated with treating depression in primary care, alternative modes of treatment 
delivery have been proposed to increase the efficiency, accessibility, and effectiveness of 
mental health services.  
One alternative to traditional, clinic-based care is the use of less intensive, more 
personalized mHealth interventions, which include mobile applications (apps). Mobile 
apps have distinct advantages over traditional mental health interventions, including 
lower costs, increased treatment accessibility, and greater retention (Donker et al., 2013). 
Additionally, these apps are generally available at little to no cost and can circumvent the 
stigmas associated with receiving professional help for psychological symptoms. Further, 
mobile apps provide individuals with the opportunity to track and monitor their 
symptoms and progress in real-time, which is a more accurate representation of their 
experience of symptoms and impact on daily life (Donker et al., 2013; Proudfoot et al., 
2010). Thus, if individuals can monitor and track their symptoms and progress, they may 
be more inclined to adhere to the recommended treatment (Proudfoot et al., 2010). These 
advantages have led to the rapid development of mobile apps in recent years, with one 
recent review reporting the existence of over 1,000 apps available for the management of 
depression (Shen et al., 2015).   
 Numerous studies have examined the impact of using mobile apps on depression. 
One way in which researchers have explored the effectiveness of apps is by investigating 
whether individuals who utilize an app experience a statistically significant reduction of 
depressive symptoms. Preliminary evidence suggests that using mobile apps can reduce 
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depressive symptoms. For example, in their meta-analysis of 18 randomized controlled 
trials with 22 mobile apps, Firth et al. (2017) found that individuals using mobile apps to 
manage depressive symptoms experienced a significant reduction of symptoms when 
compared to control conditions (g=0.38, p<0.001). The authors reported moderate effect 
sizes compared to inactive control groups (g=0.56) and small effect sizes compared to an 
active control condition (g=0.22). In a large scale randomized controlled trial, Moberg et 
al.  (2019) found that participants utilizing the mobile app Sanvello (i.e., Pacifica) 
experienced greater decreases in depression (d=0.54, p<.001), anxiety (d=0.40, p<.01), 
and the Depression Anxiety and Stress Scales-21 (DASS-21) scores (d=0.46, p<.001) at 
4-weeks post-intervention when compared to the waitlist control condition.  
 Another way of defining outcome is through examining remission rates or 
clinically significant reductions of depressive symptoms. While definitions of remission 
rates vary across studies, evidence suggests that some individuals experience remission of 
depressive symptoms when utilizing mobile apps. Arean et al. (2016) evaluated remission 
rates, as defined by a reduction of pre-treatment Patient Health Questionnaire-9 (PHQ-9) 
scores of at least 50%, in three self-guided mobile apps: a problem-solving application, a 
cognitive training application, and a health information application, which served as the 
active control group. Results indicated that 45 out of the 100 participants (45%) 
randomized to the cognitive training application and 36 out of 79 participants (46%) 
randomized to the problem-solving therapy app experienced a remission of symptoms. In 
comparison, 34 out of 100 participants (34%) of the control condition participants 
experienced remission. Pratap et al. (2018) evaluated recruitment, engagement, and 
remission rates of individuals experiencing depressive symptoms, utilizing the same 
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conditions as Arean and colleagues. In this study, remission was defined as a decrease in 
PHQ-9 scores of at least 5 points or more from baseline. They found 117 out of 345 
participants (34%) experienced a remission of symptoms. However, results also indicated 
that 51% of participants were "nonresponders" (i.e., experiencing a change in PHQ-9 
scores of <5 points), and 11% experienced an increase in depressive symptomology. 
 In addition to examining whether apps can reduce depressive symptoms or cause 
a remission of symptoms, studies have also explored whether the severity of symptoms 
one experiences influences the effectiveness of mobile apps. Results from these studies 
are mixed. For example, a recent meta-analysis revealed moderate effect sizes (g=0.51) 
for individuals with self-reported mild to moderate depressive symptoms, suggesting that 
mobile apps may be most effective for this subsample of depressed patients (Firth et al., 
2017). In contrast, Pratap et al. (2018) found that changes in depressive symptomology 
were significantly associated with baseline severity of symptoms, in that participants who 
endorsed severe depressive symptoms experienced the greatest reduction of depressive 
symptoms during the first four weeks of treatment (beta=4.19, p<.001). The findings 
from Pratap et al. (2018) not only stand in contrast to results from Firth et al. (2017) but 
also to the existing self-help literature, which recommends the use of self-help 
interventions for mild to moderate depressive symptoms (Clarke et al., 2009; Cuijpers et 
al., 2010). Therefore, they may need further replication.  
 A more recent question being explored in the literature is related to the long-term 
effects of mobile apps for depression. Results from these studies are also mixed. For 
instance, Arean et al. (2016) found no significant changes in PHQ-9 scores at the 12-
week follow-up. Similarly, Pratap et al. (2018) found no significant reductions of PHQ-9 
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scores across conditions at the 12-week follow-up. On the other hand, Moberg et al. 
(2019) found that two months post-intervention, the rates of clinically significant changes 
for participants in the Pacifica condition was 35% for the PHQ-8 (compared to 42% at 
four weeks-post baseline). Given the issues with retention and engagement in both Arean 
et al. (2016) and Pratap et al.'s (2018) studies, the long-term effects of mobile apps may 
be related to one's engagement with the mobile app. 
While the results from these studies indicate that mobile apps have the potential to 
effectively treat depressive symptoms, there are several gaps within the current literature. 
First, most mobile apps currently available to the general public have been inadequately 
evaluated for their effectiveness in treating depressive symptoms (Donker et al., 2013; 
Firth et al., 2017). For example, Martinez-Perez et al. (2013) found that out of the 1,536 
depression apps available to the general public, only 32 published articles evaluated the 
effectiveness of depression apps.  
Second, many of the published studies have been plagued with retention and 
engagement issues; however, it is unclear what factors contribute to these issues and the 
user end experience of utilizing a mobile app. For example, Arean et al. (2016) reported 
that 58% of the 626 participants did not download either of the two intervention apps. 
Those who did download and use the app, only used the mobile app an average of eleven 
times over the course of four weeks. Pratap et al. (2018) successfully enrolled 1040 
participants; however, only approximately 34% (348 out of 1040) were active in the 
study, as defined by completing at least one PHQ-9 measure. Furthermore, by week 4 of 
the study, approximately 50% of participants dropped out. Given these issues with 
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engagement and retention, it is important to understand factors that might motivate app 
engagement and prolong app usage. 
Third, the studies to date have neglected to examine patient preferences towards 
specific mobile apps. Mobile apps offer more flexibility than routine clinical care, as 
patients can select mobile apps based on their individual preferences. Additionally, there 
is evidence to suggest that primary care patients have specific preferences regarding the 
type of psychotherapy they would prefer to receive (e.g., cognitive therapy, behavioral 
activation, problem-solving therapy, interpersonal psychotherapy, and mindfulness) if 
they were to seek treatment for depression (Haugh et al., 2019). Specifically, Haugh et al. 
(2019) conducted a cross-section survey to assess the acceptability of the stepped care 
model of depression treatment and treatment preferences in a group of primary care 
patients. Results indicated that participants most frequently preferred cognitive therapy 
(28%, n=26), followed by problem-solving therapy (25%, n=24), mindfulness (18%, 
n=17), behavioral activation (17%, n=16), and interpersonal (12%, n=11). Further, 
numerous studies have indicated that incorporating patient treatment preferences 
throughout treatment improves clinical outcome (Firth et al., 2015; Lin et al., 2005; Swift 
& Callahan, 2009), increases adherence (Kwan et al., 2010), and reduces rates of attrition 
(Swift & Greenberg, 2015). Thus, examining patient preference for mobile apps might 
help us understand factors that could enhance treatment outcomes.  
Finally, these apps have yet to be examined within the context of primary care. 
Due to the barriers of accessing mental health care, the potential costs of untreated or 
inadequately treated depression, and existing gaps in the literature regarding the modest 
quantity and poor quality of most empirical evidence to date, it is necessary to explore 
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mobile apps for treating depression in primary care settings. Through such research, we 
might improve the accessibility, efficiency, and effectiveness of mental health services 
within primary care. 
Therefore, this study's primary aim is to evaluate the feasibility and acceptability 
of implementing three mobile apps designed to ameliorate depressive symptoms within 
primary care. Specifically, this study aims to evaluate the feasibility of recruitment, 
randomization, retention, assessment procedures, and participant engagement with the 
mobile apps. Participants will be randomized, with a 1:1:1:1 allocation, to receive a) 
MoodTools, a cognitive behavioral therapy app, b) Moving Forward, a problem-solving 
therapy app, c) Mindfulness Coach, a mindfulness-based app, or d) the waitlist control 
condition. Regarding acceptability, previous research suggests that both patients and 
physicians in primary care find these mobile delivery methods acceptable (Haugh et al., 
2019). Furthermore, most patients in that sample (44%, n=57) reported if they were to 
seek treatment for depressive symptoms, they would prefer to begin treatment with a self-
help intervention, specifically delivered via a mobile app.  
The secondary aim is to examine whether participants utilizing a mobile 
application will experience a reduction of depressive symptomology and improvements 
in quality of life when compared to a waitlist control condition. Based on previous 
literature, we hypothesize that patients utilizing mobile apps will show a clinically 
significant reduction in depressive symptoms and improved quality of life when 












Variable Participant 1 Participant 2 Participant 3 
Age 21 33 27 
Gender Identity Man Woman Woman 
Marital Status Prefer not to 
answer 
Never married Married 
Race White White White 






Education Associate Degree Associate Degree Associate Degree 
Employment Status Full-time Part-time Full-time 
Income $25,000-$49,000 Less than $14,999 $25,000-$49,000 
Insurance Medicare only Medicaid Private or 
commercial 
insurance 
Medication -- Zoloft Lexapro & 
Wellbutrin 






Variable Participant 1 Participant 2 Participant 3 
Previous 
Psychotherapy 
No Yes Yes 
How long ago did you 
receive psychotherapy 
for depression? 
-- 3 or more years ago 3 to 6 months ago 
Satisfaction with 
Treatment 
-- Somewhat satisfied Somewhat satisfied 
Do you believe that 
the treatment you 
received was helpful? 
-- Somewhat agree Somewhat agree 
During the past 12 
months, was there any 
time when you 
needed mental health 
treatment but did not 
get it? 
-- No Yes 
   Reasons for not 
seeking treatment 





Participants one and two were randomized to the Mindfulness Coach app, and 
participant three was randomized to the MoodTools App. Due to low enrollment rates, 
there were no participants randomized to the waitlist control condition as initially 
planned.  
Setting and Procedure 
Participants were recruited between August 25, 2019 and March 12, 2020 from 
two Family Medicine clinics affiliated with the School of Osteopathic Medicine at 
Rowan University. Due to the COVID-19 pandemic, recruitment for this project was 
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prematurely terminated on March 15, 2020. At that time, Rowan University required all 
students to cease all in-person data collection that would put them in direct contact with 
the public. Additionally, the Family Medicine clinics affiliated with the School of 
Osteopathic Medicine only allowed essential employees in the facility and did not allow 
in-person recruitment for research protocols. When the first author left for a doctoral 
internship in June of 2020, these policies remained. 
Eligibility Criteria 
Initial eligibility criteria required participants to (1) be at least 18 years of age or 
older, (2) own an iPhone with Wi-Fi or 3G/4G capabilities, and (3) obtain a score 
between five and fourteen on the nine-item Patient Health Questionnaire (PHQ-9). For 
those who were managing their depression through psychotropic medication, their 
medication regimen must have been stable for six weeks. This information was 
confirmed through the patient and their primary healthcare provider.  
Participants were deemed ineligible if they (1) scored fifteen or higher on the 
PHQ-9 at prescreening, (2) were actively suicidal or exhibiting suicidal ideation (as 
determined by an endorsement of one or higher on item 9 on the PHQ-9 at prescreening), 
(3) were receiving psychotherapy (by self-report), (4) were pregnant (by self-report), or 
(5) had a self-reported history of bipolar disorder, substance use disorder, dementia, 
neuro-developmental disorders, or schizophrenia spectrum disorders. Before approaching 
a patient, a member of the research team asked their primary care provider if the patient 






Participants were prescreened using the PHQ-9. Yearly administration of this 
instrument was already a routine practice at these locations. The certified medical 
assistants notified a member of the research team of patients who scored between five 
and fourteen on the PHQ-9. A member of the research team approached those patients 
following their visit with their provider to explain the study, assessed interest and 
eligibility, and completed informed consent. After informed consent, participants 
completed the baseline survey. The first section of the baseline survey comprised 
questions inquiring about sociodemographic information, mental health treatment history, 
barriers to engaging in mental health treatment, treatment preferences, and health service 
utilization. Additionally, participants completed the following measures: The Patient 
Health Questionnaire-8 (PHQ-8), Self-Report Quality of Life (SF-36), The Five Facet 
Mindfulness Questionnaire (FFMQ), The Social Problem-Solving Inventory-Revised: 
Short Form (SPSI-R: SF), and the Automatic Thoughts Questionnaire-Negative (ATQ-
N). The survey was administered through Qualtrics, an online survey platform, via an 
iPad. 
After completing the baseline assessment, all participants were then randomized 
with a 1:1:1:1 allocation to receive a) MoodTools, a cognitive behavioral therapy app, b) 
Moving Forward, a problem-solving therapy app, c) Mindfulness Coach, a mindfulness-
based app, or d) the waitlist control condition. Participants randomized to the waitlist 
control condition would be informed that they would have access to the mobile apps after 
completing the final study survey. They would also be given the opportunity to be re-
entered into the study using their most preferred mobile application.  
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For participants randomized to a mobile app condition, a member of the research 
team helped all participants download the mobile application and provided brief training 
(~10 minutes) on the mobile application's specific features and how to use the mobile 
application effectively. Participants were also provided with a link to an instructional 
YouTube video created by the study coordinator on the app's specific features and how to 
use it effectively. Participants were encouraged to use the mobile app daily but were 
asked to use it at least once per week.  
Participants were contacted via email weekly by the research study coordinator to 
help with any difficulties or problems encountered when using the mobile application. 
Within that email, participants were provided with a link to a brief Qualtrics survey 
containing the PHQ-8 and two questions inquiring about how often they use the mobile 
app (i.e., "How many days per week, on average, did you use the app" and "On average, 
how many total minutes do you spend using the app per day").   
All measures were completed via Qualtrics. Outcomes were assessed at three time 
points: baseline, post-treatment (i.e., six weeks later), and follow-up (i.e., ten weeks after 
baseline). The post-treatment and follow-up surveys comprised the same questions and 
measures as the baseline, except for questions inquiring about sociodemographic 
information, mental health treatment history, barriers to engaging in mental health 
treatment, and treatment preferences. Additionally, for participants who were randomly 
assigned to an app condition, the post-treatment survey included questions about the 
acceptability of and satisfaction with the mobile app used throughout the study. 
Participants received compensation for each survey packet they returned. 
Specifically, participants were given a $10 gift card for completing the baseline survey, a 
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$15 gift card for completing the post-treatment survey, and a $20 gift card for completing 
the follow-up survey (total possible compensation for completion of all surveys was $45). 
The University's Institutional Review Board approved this study.  
Mobile Apps 
The mobile apps used in this study were chosen based on their consistency with 
evidence-based treatments for depression as outlined on the American Psychological 
Association's Society for Clinical Psychology's website (Society for Clinical Psychology, 
2020) and those endorsed by the American Academy of Family Medicine (Rebebrew, 
2018). Clinical practice guidelines for treating depression recommend the use of 
empirically supported treatments, including behavioral therapy, cognitive therapy, 
cognitive-behavioral, mindfulness-based cognitive therapy, interpersonal psychotherapy, 
psychodynamic psychotherapies, and problem-solving therapy (American Psychological 
Association, 2019; Society for Clinical Psychology, 2020). Based on the apps available 
within the Apple app store, three treatments were selected: cognitive-behavioral, social 
problem-solving, and mindfulness. We then selected three apps based on their 
consistency with the underlying theory, ease of use, design quality, and cost (i.e., free).  
The cognitive-behavioral-based app, MoodTools (version 1.6), was created by 
Inquiry Health LLC. MoodTools provides users with information on the components of 
cognitive-behavioral therapy. The application focuses on teaching individuals how to 
monitor and challenge maladaptive beliefs and increase engagement in previously 
enjoyable activities. The social problem-solving app, Moving Forward (version 1.3), was 
created by the Department of Veterans Affairs and the Department of Defense. This 
application was designed to help individuals identify their problem-solving style, 
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understand factors that inhibit problem-solving abilities, teach patients how to effectively 
solve problems, and provide the ability to track progress over time. The mindfulness-
based app, Mindfulness Coach (version 2.3), was created by the Department of Veterans 
Affairs. This application focuses on teaching individuals how to engage in mindfulness 
practice. The application provides users with information on mindfulness, 21 audio-
guided mindfulness exercises, and allows users to track their progress over time.   
Measures 
Participants were asked to indicate their gender identity, age, marital status, racial 
identity, ethnicity, level of education, employment status, and income. Participants were 
also asked to provide information regarding their current health insurance status, prior 
engagement in psychotherapy, and prior and current psychopharmacological treatment. 
The following variables were also measured.   
Treatment Preference  
Participants were asked to indicate their strength of preference for the mobile 
application on a 5-point Likert scale ranging from 1 (Not strong) to 5 (Very strong). Prior 
to this, they were provided with a brief overview of problem-solving therapy, cognitive-
behavioral therapy, and mindfulness and asked to indicate which of those treatments they 
would prefer and the strength of that preference.  
Barriers to Mental Health Treatment 
One question from the National Comorbidity Survey Replication (Mojtabi et al., 
2011) regarding reasons for not seeking mental health treatment was included in this 
survey. More specifically, participants were asked, "During the past 12 months, was there 
any time when you needed mental health treatment or counseling for yourself but did not 
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get it?" If participants answered "yes" to this question, they were then able to select from 
a list of 14 statements that included reasons involving structural barriers (e.g., 
transportation, financial/insurance concerns), low perceived need for treatment, the desire 
to handle the problem on their own, the presence of stigma, and concerns that therapy or 
counseling would not be helpful.  
Feasibility 
In accordance with recommendations from Leon et al. (2011), feasibility was 
assessed through the following variables: number of participants screened per month; 
number enrolled per month; the proportion of those eligible participants who enrolled in 
the study; participant adherence to the protocol, as measured through self-reported daily 
use of the app; the proportion of planned assessments completed by participants; and 
duration of assessments.  
Acceptability  
Acceptability was assessed via a self-report measure created by the author. These 
questions were modified from Arigo et al. (2015). Participants were surveyed about their 
satisfaction with the application, perceived effectiveness, the likelihood of participating 
in the study again, whether they would recommend the application to a friend or family 
member with depression, and level of confidence regarding future use of the app and use 
of specific skills. Items were rated on a 5-point Likert scale. Participants were also 
encouraged to provide written feedback about the mobile app features they liked the most 
and least, specific ways in which the mobile app helped them manage depressive 
symptoms, recommendations for improvements, and whether they still needed assistance 
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managing specific depressive symptoms. This measure contains a total of 12 items. See 
Appendix A for the full measure.  
Health Service Utilization 
Health service utilization was evaluated using a self-report measure created by the 
author. Participants were asked to indicate how often they used specific health care 
services (i.e., medical/specialty services, primary care, emergency department, and 
psychiatry services) in the past month and the purpose of those visits. This measure 
consisted of 10 items. See Appendix B for the full measure.  
The Patient Health Questionnaire-9 (PHQ-9) 
The PHQ-9 is a 9-item self-report questionnaire that assesses each of the DSM-5 
criteria for Major Depressive Disorder (MDD; Kroenke et al., 2001). Items are rated on a 
4-point Likert scale, ranging from 0 (not at all) to 3 (nearly every day). Total scores on 
the PHQ-9 range from 0 to 27, and a total score of 10 or greater is used as a clinical cut-
off for the indication for a probable DSM-5 diagnosis of MDD. The PHQ-9 has high 
sensitivity (88%) and specificity (88%); (Kroenke et al., 2001) and excellent validity and 
reliability (Kroenke et al., 2001).  
The Patient Health Questionnaire-8 (PHQ-8) 
The PHQ-8 is an 8-item self-report questionnaire that assesses eight of the nine 
DSM-5 criteria for Major Depressive Disorder (MDD; Kroenke et al., 2009). The ninth 
item, which assesses thoughts of death and self-harm, is omitted.  Items are rated on a 4-
point Likert scale, ranging from 0 (not at all) to 3 (nearly every day). Total scores on the 
PHQ-8 range from 0 to 24, and a total score of 10 or greater is used as a clinical cut-off 
for the indication for a probable DSM-5 diagnosis of MDD (Kroenke et al., 2009). 
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Treatment recommendations for individuals who endorse scores between five and 
fourteen include watchful waiting, education, self-management, psychotherapy, or 
medication (DeJesus et al., 2007). Individuals who endorsed scores of fifteen or higher 
warrant treatment for depression using antidepressant medication, psychotherapy, or a 
combination of the two (DeJesus et al., 2007). Therefore, these individuals proceeded 
with the level of care recommended by their primary care provider. 
36-Item Short Form Health Survey (SF-36)  
The SF-36 is a 36-item self-report questionnaire that assesses health status and 
quality of life (McHorney et al., 1993). The SF-36 consists of eight subscales that are 
intended to measure health-related quality of life: the physical functioning subscale 
consists of 10 items, the role limitations due to physical health subscale consists of 4 
items, the role limitations due to emotional problems subscale consists of 3 items, the 
energy/fatigue subscale consists of 4 items, the emotional well-being subscale consists of 
5 items, the social functioning subscale consists of 2 items, the pain subscale consists of 2 
items, and the general health subscale consists of 5 items. Items are rated on a Likert-
scale, with some items rated on a 5 or 6-point scale and others on a 2 or 3-point scale. 
The eight subscales demonstrate excellent reliability, with alpha coefficients of .93, .84, 
.83, .86, .90, .85, .78, and .78, respectively (McHorney et al., 1993). 
As part of a larger project, participants also completed the following measures.  
The Five Facet Mindfulness Questionnaire (FFMQ) 
The FFMQ is a 39-item self-report questionnaire developed to assess mindfulness 
skills (Baer et al., 2006). Baer et al. (2006) used exploratory factor analysis to examine 
the facet structure of five independently developed self-reported mindfulness 
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questionnaires: The Mindful Attention Awareness Scale, The Freiburg Mindfulness 
Inventory, The Kentucky Inventory of Mindfulness Skills, The Cognitive and Affective 
Mindfulness Scale, and The Mindfulness Questionnaire. Results from the exploratory 
factor analysis yielded five independent, yet related, facets of mindfulness: the Observe 
subscale consists of 8 items, the Describe subscale consists of 8 items, the Acting with 
Awareness subscale consists of 8 items, the Nonjudging of inner experience subscale 
consists of 8 items, and the Nonreactivity to inner experience subscale consists of 7 
items. Items are rated on a 5-point Likert scale, ranging from (1) never or very rarely true 
to (5) very often or always true. The five separate subscales, Observe, Describe, Acting 
with Awareness, Nonjudging of inner experience, and Nonreactivity to inner experience 
demonstrate high internal consistency (Cronbach's alpha = .83, .91, .87, .87, and .75, 
respectively; Baer et al., 2006).  
The Social Problem-Solving Inventory-Revised: Short Form (SPSI-R: SF) 
The SPSI-R: SF is a 25-item self-report questionnaire that assesses two kinds of 
problem-solving orientations and three problem-solving styles (D'Zurilla et al., 2002). 
Items are rated on a 5–point Likert, ranging from (0) not at all true of me to (4) extremely 
true of me. The SPSI-R-SF measures all five dimensions of the social problem-solving 
model, including Positive Problem Orientation (PPO; 5 items), Negative Problem 
Orientation (NPO; 5 items), Rational Problem-solving Style (RPS; 5 items), Impulsive–
Careless Style (ICS; 5 items), and Avoidance Style (AS; 5 items). The SPSI-R-SF 
demonstrates high internal consistency (Cronbach's alpha = .93) and test-retest reliability 
(r=.84) for the total score. The five separate subscales (PPO, NPO, RPS, ICS, and AS) 
demonstrate moderate to high internal consistency (Cronbach’s alpha = .79, .80, .88, .78, 
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and .89 respectively) and adequate test re-test reliability (r=.72, .79, .74, .72, and .73, 
respectively, D’Zurilla et al., 2002) in young adult and adult samples. 
Automatic Thoughts Questionnaire –Negative (ATQ-N) 
The ATQ-N is a 30-item self-report questionnaire that assesses the frequency of 
negative automatic cognitions associated with depressive symptoms (Hollon & Kendall, 
1980). Items are rated on a 5–point Likert scale, ranging from (1) not at all to (5) all the 
time. Total scores range from 30 to 150. The ATQ-N demonstrates high internal 
consistency (Cronbach’s alpha = .96; Hollon & Kendall, 1980). 
Data Analyses 
Data analyses were conducted using IBM SPSS 27 and Microsoft Excel 2020 for 
graphical representations of data. Descriptive analyses are used to present the frequency 
and duration of app use, completion time of study surveys, and acceptability of the 
mobile apps. Individual participant changes in depressive symptoms and self-reported 















Establishment of the Research Team  
 The research team comprised a full-time faculty member within the Psychology 
Department at Rowan University, a Licensed Clinical Psychologist and Physician from 
the Department of Family Medicine, two advanced level doctoral students, one 
undergraduate research assistant, and one post-baccalaureate research assistant. 
Recruitment Team. Recruitment was completed by one doctoral-level student, 
one undergraduate research assistant, and one post-baccalaureate research assistant. 
Recruitment team members were available for recruitment for a total of 16 hours per 
week. The licensed clinical psychologist and physician from the Department of Family 
medicine prescreened potential patients at the beginning of each week for the research 
assistants to approach. 
Primary Care Office Staff. The primary care staff comprised family medicine 
residents, physicians, nurse practitioners, and certified medical assistants.  
Screening and Recruitment  
Screening and recruitment data are displayed in Figure 1. Approximately 5.33 
patients were screened per month, resulting in 35 potential participants. Over a six-month 
period, 35 primary care patients were screened, and three were enrolled, resulting in an 
8.6% screening to enrolled ratio. Of those not enrolled, sixteen did not meet the inclusion 
criteria, seven declined to participate, three did not finish screening, and six patients 
could not be contacted after expressing interest in the study. As displayed in Figure 1, 
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two participants were randomized to the Mindfulness Coach condition and one 
participant was randomized to the MoodTools condition. No participants were 
randomized to the MovingForward or Waitlist Control conditions because of initial low 
enrollment. However, and most importantly, pandemic circumstances precluded 
additional data collection. 
 
Figure 1 




Retention Rates & Treatment Adherence 
As displayed in Figure 1, all three participants completed the 6-week intervention 
and the post-treatment survey, yielding a 100% retention rate. Participants were 
encouraged to use the mobile app daily but were asked to use it at least once per 
week. Participants' app use (i.e., days per week and minutes per day) is presented in 
Table 2.  
 
Table 2 
Participants' Mobile App Use 
Participant Onea 
Survey App Use (Average days per week) Minutes per use 
Week 1 Rarely (1 Day) 7 
Week 2 Some of the time (2-3 days) 5 
Week 3 Did not complete survey -- 
Week 4 Did not complete survey -- 
Week 5 Some of the time (2-3 days) 5 
Week 6 Some of the time (2-3 days) 7 
Participant Twob 
Survey App Use (Average days per week) Minutes per use 
Week 1 A moderate amount of the time (4-5 
days) 
5 
Week 2 Did not complete survey -- 
Week 3 Did not complete survey -- 
Week 4 A moderate amount of the time (4-5 
days) 
5 
Week 5 Did not complete survey -- 
Week 6 Some of the time (2-3 days) 2 
Participant Threec 
Survey App Use (Average days per week) Minutes per Use 
Week 1 Some of the time (2-3 days) 10 
Week 2 Some of the time (2-3 days) 10 
Week 3 Some of the time (2-3 days) 5 
Week 4 Rarely (1 day) 5 
Week 5 Some of the time (2-3 days) 5 
Week 6 Not at all 0 
a Participant one tracked their app use for four out of the six weeks of the intervention. 
b Participant two tracked their app use for three out of the six weeks of the intervention.  
c Participant three tracked their app use during all six weeks of the intervention.  
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As displayed in Table 2, none of the participants engaged with the app daily; 
however, two of the three participants used the app two to three days per week, for 
approximately 5 minutes during each use. Participants who completed the follow-up 
survey indicated they continued to use the app after study completion. One participant 
used the app two to three days per week for approximately five minutes each time. 
Another participant reported using the app at least one day per week for approximately 
five minutes each time.  
Assessment Process  
Participants were asked to complete the baseline assessment, five weekly surveys, 
the post-intervention survey, and the follow-up survey. As presented in Figure 1, 
participation in the weekly surveys varied, and the week one survey was the only survey 
completed by all three participants. Two out of three participants completed the weeks 
two, four, and five surveys, while only one participant completed the week three survey. 
There was a 100% completion rate for the post-intervention survey, while only two out of 
three participants (67%) completed the follow-up survey.  The average completion times 
for each survey are presented in Table 3. 
 
Table 3 
Survey Completion Times  
Survey M (in minutes) SD 
Baseline 37.19 20.78 
Week 1 1.91 0.89 
Week 2 1.45 0.31 
Week 3 1.03 -- 
Week 4 1.31 0.22 
Week 5 1.13 0.08 
Week 6 19.41 3.51 
Week 10 12.18 0.56 
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Unexpected Barriers to Screening and Recruitment 
As previously mentioned, 5.33 patients were screened per month, which was 
lower than anticipated. There were several unexpected barriers to screening and enrolling 
patients throughout the recruitment process. The first barrier was accessing potentially 
eligible patients. Members of the research team were not granted access to this 
institution's electronic medical record (EMR) system. Therefore, we were not able to 
prescreen and identify potentially eligible patients before going to the clinic. To 
overcome this barrier, both of our collaborators, who are providers within the Department 
of Family Medicine, prescreened potential participants at the beginning of the week for 
the research assistants to approach.  
A second barrier was achieving a steady referral rate from residents and 
providers. A handout was created and provided to residents and providers (see Appendix 
C for a copy of the handout). The handout explained the purpose of the study and the 
eligibility criteria. Additionally, each week the research assistants would make their 
presence known to the providers and residents and remind them about the research study. 
However, members of the research team only received five direct referrals from providers 
and residents. This could be further explained by the fact that the resident schedules 
would change every four weeks, and/or a new set of residents would come to the clinics. 
The research team members would then have to introduce the study to the new residents 
or review the study protocol and eligibility criteria with the previous residents. 
The third barrier to recruitment was the number of potential participants to 
approach varied at each location. For instance, at one of the locations, research team 
members recruited for 32 hours over 7 months and approached 11 patients. At the other 
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location, research team members recruited for 90 hours over 7 months and approached 17 
patients.  
The fourth barrier to recruitment was patients' ability to stay after their 
appointments to discuss the research study. To not disrupt clinic flow, research assistants 
were asked to approach patients after visiting with their provider. However, many 
patients often waited for extended periods of time for their provider, and some would 
immediately leave before the research assistants had a chance to approach them. There 
were also times when the research assistants would attempt to approach the patients right 
after their appointment, and they would state that they could not stay and asked to be 
contacted at a later time. 
A fifth barrier to recruitment was being unable to contact patients who requested 
follow-up calls to learn more about the study. For the six patients who requested follow-
up calls, research team members could not reach those patients despite contacting each 
patient four times after the initial meeting. More specifically, six patients were sent one 
follow-up email following their appointment. Additionally, a member of the research 
team called each patient three times on three separate occasions and left voicemails when 
possible. These patients did not return any phone calls or emails.  
The sixth barrier to recruitment was the availability of research staff to assist with 
the recruitment process. The doctoral-level student was available for recruitment sixteen 
hours per week. The undergraduate and post-baccalaureate research assistants were each 
available for recruitment four hours per week and predominantly recruited alongside the 
doctoral-level student. Additionally, during December and January, when the doctoral 
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level student was interviewing for predoctoral internship positions, recruitment occurred 
twice.  
A final barrier to recruitment was our eligibility criteria. Of the 35 patients 
approached, 45.7% (n=16) were ineligible, suggesting that our initial criteria were too 
restrictive. As seen in Figure 1, the most common reasons participants were not eligible 
to participate in this study were because they did not own an iPhone (n=5), were currently 
engaged in psychotherapy (n=3), and they endorsed item 9 (i.e., thoughts that you would 
be better off dead, or thoughts of hurting yourself in some way) on the PHQ-9 (n=3).  
Changes Made to Accelerate Recruitment 
To accelerate recruitment, two modifications were made to the initial research 
protocol. The first modification was made two months after recruitment began and 
incorporated the use of flyers advertising the study. Flyers were displayed in examination 
and waiting rooms (see Appendix D for a copy of the flyer). Additionally, primary care 
providers could refer patients to the study coordinator. The second modification was 
made seven months into recruitment and including advertising the study on the 
Department of Family Medicine's Facebook page (see Appendix E for the Facebook 
advertisement). Interested patients were directed to a link to the prescreening survey, 
which consisted of the PHQ-8 and was administered through Qualtrics. Those who were 
eligible to participate were contacted via phone or email within 24-hours to schedule an 
in-person meeting with the study coordinator to complete the recruitment and consent 
process.  
 An additional change that was made during the second modification was related 
to the eligibility criteria. The initial criterion appeared too restrictive, given that 50% of 
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the patients approached were deemed ineligible. Thus, it was decided to expand the 
eligibility criteria. Since two of the three mobile apps were available across all platforms 
(i.e., MoodTools and Mindfulness Coach) and no participants were randomized to the 
application that was only available on the iOS platform, it was decided to remove the 
MovingForward app from randomization. We also expanded the PHQ-9 inclusion criteria 
to include participants who scored between a five and twenty-four on the PHQ-9. 
However, due to the COVID-19 pandemic, recruitment for this study prematurely ended 
on March 12, 2020, and we were unable to assess to what extent the proposed changes 
would accelerate the recruitment process.  
Acceptability 
Participants answered six Likert scale questions about their willingness to 
participate in the study again, satisfaction with the application, perceived effectiveness, 
the likelihood of participating in the study again, whether they would recommend the 
application to a friend or family member with depression, and level of confidence 
regarding future use of the application and use of specific skills. Results from the 




Survey Item Participant One Participant Two Participant Three 
How likely would you 
be to participate in this 
study again? 




Survey Item Participant One Participant Two Participant Three 
How satisfied are you 





Somewhat satisfied Very satisfied 
Would you 
recommend this 
mobile application to 
a friend or family 
member with 
depression? 




Yes, I would 
strongly 
recommend it 
Yes, I would 
strongly 
recommend it 
How well do you 
think you would have 
managed your 
depressive symptoms 
during these 6 weeks 
without the mobile 
application? 
Slightly better Slightly better Slightly better 
How effective was the 
mobile application at 




Somewhat effective Somewhat effective 
How often did you 
use the skills 
suggested by the 
mobile application? 
Once a week 2-3 times per week Once a week 
How confident did 
you feel using the 
skills that were 
presented in the 









Please indicate how 
confident you are that, 
over the next three 
months, you will 









Participant feedback varied regarding views on satisfaction with the app, as 
participants one and two reported that they were "somewhat satisfied." Participant three 
endorsed being "very satisfied" with the mobile app. Despite some variability in 
satisfaction with the app, all participants reported that they would recommend the app to 
a friend or family member with depressive symptoms; however, all participants reported 
that they believe they would have managed their depressive symptoms "slightly better" 
without the mobile app. Additionally, participants two and three reported the apps were 
"somewhat effective" in helping them manage their depressive symptoms. Participant one 
reported the app was "neither effective nor ineffective".  
Acceptability was also assessed through the use of open-ended questions. 
Participants were asked to indicate factors they liked most and least about participating in 
the study and the specific features of the app they liked most and least. They were also 
asked about how the mobile app helped them manage depressive symptoms and what, if 
anything, they believed they still need help with related to managing their depressive 
symptoms. 
Qualitative feedback showed that participants two and three reported they liked 
the mobile apps the most, and participant one liked having their depressive symptoms 
normalized. The factor participants one and two liked least about the study was "having 
to complete the surveys." Additionally, participants two and three reported that "time" 
would be the only factor influencing their decision to participate in this study again.  
Regarding the mobile apps' specific features, participant one stated that they liked 
"how easy it is to use the app and how convenient it was having it on my phone." 
Participant two reported they liked the mindfulness of breath exercise the best, while 
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participant three stated, "I like how you talk yourself through a bad thought. This made 
me start to do it automatically without needing the app." Regarding features of the app's 
participants liked the least, participants two and three did not have any feedback, while 
participant one reported that they "wished there were less options to choose from."  
In terms of the specific ways the mobile app helped them manage their symptoms, 
participant one stated, "it helped me realize that my symptoms are normal and other 
people have them, I'm not the only one." Participant two reported that the app was 
relaxing and calming, while participant three stated, "when I had a negative thought, I 
thought about the app and how I may be overreacting and such." Regarding continued 
depressive symptom management, participant one reported "I feel like I'm getting a better 
grasp on it," participant two reported they need help "lowering stress," and participant 
three stated "getting motivated to get up and move and not just sit around all day."  
Treatment Preference 
  Preference for the type of mobile app was assessed by first providing participants 
with a brief overview of problem-solving therapy, cognitive-behavioral therapy, and 
mindfulness. They were then asked to indicate which of those treatments they would 
prefer and the strength of that preference on a 5-point Likert scale ranging from 1 (Not 
strong) to 5 (Very strong). Preference data is available for two out of the three 
participants, as one participant skipped this item. Participants two and three answered the 
preference questions identically. Both participants indicated a moderately strong (i.e., 





Treatment Progress & Outcomes 
Participant One 
Depression. When participant one completed the PHQ-9 in the office, with the 
CMA administering it, they endorsed a score of six, while their baseline PHQ-8 score 
was a two. During the six-week period, participant one experienced an eight-point 
increase in depressive symptoms. See Figure 2 for participant one's PHQ-8 scores 
throughout the study.  
 
Figure 2 




Quality of Life. Participant one's SF-36-SF scores are displayed in Figures 3 and 




























physical functioning, as evidenced by a 15-point decrease in their scores on this subscale 
(please see Figure 3). However, participant one reported an improvement in energy level 
and fatigue (see Figure 3) and overall health (see Figure 4) during the intervention period.  
 
Figure 3 








































Health Care Utilization. Participant one did not attend any medical 
appointments throughout the study period.  
Participant Two 
  Depression. Participant two's prescreen PHQ-9 score, and baseline PHQ-8 scores 
were a 10. During the six-week period, participant two experienced a four-point decrease 
in depressive symptoms. On the follow-up survey, participant two reported a two-point 
increase in depressive symptoms, resulting in a PHQ-8 score of 8; however, their final 
PHQ-8 score remained two points lower than the score reported at baseline. Participant 






























Quality of Life. Participant two's SF-36-SF scores are displayed in Figures 6 and 
7. During the six-week intervention, participant two experienced a decline in physical 
functioning (a 30-point difference in scores; see Figure 6), role limitations due to 
emotional problems (a 100-point difference in scores; see Figure 6), energy and fatigue 
(30-point difference in scores; see Figure 6), and general health (5-point difference; see 
Figure 7). However, they did experience an improvement in role limitations due to 
physical functioning (25-point increase; see Figure 6), emotional well-being (8-point 




























point increase; see Figure 7) over the course of the intervention. At the follow-up survey, 
participant two reported a decline in scores on the following subscales: physical 
functioning (10-point decrease see Figure 6), emotional well-being (8-point decrease, see 
Figure 7), pain (20-point decrease, see Figure 7), and general health (12-point decrease, 
see Figure 7). They endorsed an improvement in role limitations due to emotional 
problems (100-point increase, see Figure 6) and energy and fatigue (10-point increase, 
see Figure 6). 
 
Figure 6 
































Health Care Utilization. Participant two attended five medical appointments 
during the 10-week period, which includes both specialty and family medicine care. The 
reasons for all appointments included either getting a "check-up" or refilling 
prescriptions. 
Participant Three 
Depression. At the prescreen, participant three endorsed a score of 10 on the 
PHQ-9; however, they endorsed a score of 17 when completing the PHQ-8 at baseline. 
During the six-week period, participant three experienced a four-point decrease in 





























participant three reported a two-point decrease in depressive symptoms, resulting in a 
final PHQ-8 score of 11. Participant three's PHQ-8 scores throughout the study are 
presented in Figure 8. 
 
Figure 8 




Quality of Life. Participant three's SF-36-SF scores are displayed in Figures 9 
and 10. During the 6-week intervention, participant three experienced an improvement in 
role limitations due to emotional problems (33-point increase, see Figure 9), energy and 
fatigue (15-point increase, see Figure 9), emotional well-being (40-point increase, see 
Figure 10), and social functioning (13-point increase, see Figure 10). They experienced a 

































decrease, see Figure 9) and no changes in scores on the physical functioning (see Figure 
9) and pain subscales (see Figure 10). At the follow-up survey, improvements in role 
limitations due to emotional problems (see Figure 9) remained. They also experienced an 
improvement in energy and fatigue (5-point increase, see Figure 9) and role limitations 
due to physical functioning (25-point increase, see Figure 9). However, they did 
experience a decline in scores on the following subscales: emotional well-being (20-point 
decrease, see Figure 10) and social functioning (13-point decrease, see Figure 10). Their 
scores on the general health subscale did not change from the post-intervention survey to 
the follow-up survey (see Figure 10). 
 
Figure 9 




























Health Care Utilization. Participant three attended two medical appointments 
during the 10-week period, which also included specialty and family medicine care. The 


































The primary aim of this study was to evaluate the feasibility and acceptability of 
three mobile apps designed to ameliorate depressive symptoms within primary care. The 
secondary aim was to examine whether mobile app use would reduce depressive 
symptomology and improve quality of life. The insights gained from this study were 
examined in order to inform future, larger scale studies in this area. The following is a 
review the major themes of study regarding feasibility and acceptability, discussion of the 
study limitations, and implications for future directions of research.  
Feasibility  
 Feasibility outcomes included recruitment, randomization, retention, assessment 
procedures, and participant engagement with the mobile apps. Recruitment proved to be 
most challenging. There were two main factors that interfered with the successful 
recruitment of participants. One was the limited number of patients we were able to 
approach and the second was the initial eligibility criteria.  
Access to Patients 
It is possible that the recruitment challenges faced could be best explained by 
issues related to the number of patients we were able to approach. Over the course of 
seven months and 122 total hours of recruitment, only 35 patients were approached or 
contacted about the study. Due to the low volume of patients approached during the first 
few months of recruitment, several attempts were made to improve recruitment efforts, 
including advertising the study via flyers posted in the waiting room and exams room, 
advertising the study on the Department of Family Medicine’s Facebook page, and 
41 
 
receiving referrals from physicians. In addition, a handout, which explained the purpose 
of the study and eligibility criteria, was given to providers. Each week the research 
assistants would also make their presence known to the providers and residents and 
remind them about the research study. The data demonstrates these efforts did not 
drastically improve the number of patients we had access to, as we only received five 
referrals from providers and six referrals from the Facebook post and waiting/exam room 
flyers.  
The final modification made to improve recruitment included removal of the iOS 
specific app and expansion of PHQ-9 inclusion criteria to include scores ranging from 
five to twenty-four. While the COVID-19 pandemic impacted our ability to assess 
whether this modification would have accelerated recruitment, difficulty recruiting within 
primary care is a commonly cited problem within the literature (Bell-Syer & Moffett, 
2000; Chew-Graham et al., 2007; Johnston et al., 2010; Kaur et al., 2012; Malhotra et al., 
2017). For example, barriers to recruitment have included lack of staff and training, 
provider time constraints and heavy workload, provider difficulties remembering 
eligibility criteria, concerns about the demands of the research on the patient, worry about 
the efficacy of the treatment, interruption of patient flow, lack of familiarity of research 
objects, forgetfulness, and clinical relevance of the research (Bell-Syer & Moffett, 2000; 
Kaur et al., 2012). The literature also suggests several strategies to improve recruitment 
rates, including use of physician recruiters, having an in clinic “champion” for the 
research project, minimizing the burden of participation on the practice, have clear and 
simple eligibility criteria, and building personal connections with the providers and staff 
within the clinics (Johnston et al., 2010). Although much of this research is from the 
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United Kingdom, these recruitment insights are applicable to this study based in the 
northeastern United States.  
Eligibility Criteria 
The results indicated the initial eligibility criteria were too restrictive. About 47% 
of participants approached did not meet initial eligibility criteria. This was a surprising 
outcome given our eligibility criteria were similar to other studies with better enrollment 
rates (Arean et al. 2016; Dahne et al., 2019; Moberg et al., 2019; Pratap et al. 2018; 
Roepke et al., 2015). The three most frequent reasons participants were not eligible to 
participant were because they did not own an iPhone (n=5), endorsed a score of one or 
higher on item 9 on the PHQ-9 (i.e., how often have you been bothered by thoughts that 
you would be better off dead, or of hurting yourself; n=3), or were currently engaged in 
psychotherapy (n=3).  
The decision to exclude Android and other smart phone owners was due to one of 
the mobile apps (MovingForward) only being available on iOS platforms. Previous 
studies overcame this barrier by providing participants with an iPhone or other iOS 
products (e.g., Dahn et al., 2019). This approach was not possible for our research study 
due to insufficient funding. However, providing mobile devices to suit desired app 
platforms may be an alternative for future larger scale studies with increased budgets for 
such allocations. Given the fact that approximately 47% of all smartphone users in the 
United Stated own an Android smartphone (Statisa, 2021), it may be more feasible and 
fiscally responsible for future researchers to identify and evaluate mobile apps that are 
common across all platforms. 
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 In addition, participants who endorsed a score of one or higher on item 9 on the 
PHQ-9 were excluded because the research team was not able to screen and track risk 
over time. The exclusion of participants indicating risk of self-harm or suicide is 
consistent with previous studies (Arean et al., 2016; Dahne et al., 2019). However, it is 
worth noting the face validity of this item does not extend to the evaluation or assessment 
of suicidal ideation, but rather morbid thoughts or thoughts of self-harm. Therefore, it is 
worth questioning whether this criterion for exclusion should be used in future studies 
without further assessment for suicidality or other risk factors, such as prior suicide 
attempts, misuse and abuse of alcohol or substances, and access to lethal means (Suicide 
Prevention Resource Center, 2021).  
 Several studies have examined the relationship between endorsement of item 9 
and suicidal ideation, plan, and attempts. Na and colleagues (2018) examined the positive 
predictive value, sensitivity, and specificity of item 9 on the PHQ-9 when compared to 
assessment of suicidality using the Columbia Suicide Severity Rating Scale (C-SSRS). 
Results indicated that approximately 41% out of 841 patients were identified as being 
suicidal through the PHQ-9 compared to 13.4% of patient who completed the C-SSRS. 
The authors concluded that item 9 on the PHQ-9 has low positive predictive validity and 
specificity, which suggests that this item is an inadequate assessment tool for suicidality. 
Corson et al. (2004) evaluated the proportion of primary care patients who would screen 
positive for depression and suicidality using the PHQ-2, the PHQ-9, and a structured 
clinical interview. Out of 962 primary care patients, 7% reported thoughts of death or 
suicide, 2% reported thoughts of self-harm, and 1% reported having a specific plan for 
suicide. Additionally, the authors found that approximately one third of the patients who 
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endorsed item 9 reported active suicidal ideation. Razykov et al. (2012) found that 110 
(10.8%) out of 1,022 coronary artery disease patients endorsed a score of 1 or higher on 
item 9. Of those 110 patients, 22 (19.8%) reported suicidal ideation and 9 (8.1%) reported 
thinking about a specific plan to commit suicide in the last year. Walker et al. (2011) 
evaluated the nature of thoughts of death and suicide in a sample of oncology patients 
who endorsed item 9 on the PHQ-9. Results indicated that two thirds of the sample 
(n=330) who endorsed item 9 denied any thoughts that they would be better off dead or 
endorsed morbid thought but denied suicidal ideation on follow up. Results of these 
studies suggest endorsement of item 9 may not warrant immediate exclusion from 
participation in the study. Rather, item 9 should be utilized in conjunction with additional 
risk assessment tools to accurately assess for eligibility.  
Retention 
Despite the issues encountered during recruitment, retention was high across the 
study duration. All three participants completed the post-intervention survey, and two of 
the three participants completed the follow-up survey. Additionally, participants were 
engaged with the app throughout the study duration, with all three participants reporting 
they used the app on average one to three times per week across the 6-week intervention 
period. Two out of the three participants reported continued use at the follow-up survey. 
It is possible that our retention and engagement rates were high due to our initial 
recruitment efforts of participants. In the current project, participants were recruited in-
person, and a member of the research team spent approximately ten minutes showing 
participants how to use the app and answering questions about the app. Additionally, 
participants were provided with a link to a YouTube video reviewing the features of the 
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app. Furthermore, participants were sent weekly surveys inquiring about their app use 
and current depressive symptoms, potentially serving as reminders to engage with the 
app. Participants also were informed of their ability to contact the study coordinator via 
email at any time with questions about app or their participation in the study. These 
efforts are consistent with previous literature that has found lower retention rates in trials 
where participants were required to have either a telephone or in-person interview or 
meeting with the research staff (Linardon & Fuller-Tyszkiewicz, 2019). Additionally, 
trials that offer monetary incentives, reminded participants to engage with the mobile 
app, offer feedback from research team members, and incorporate some level of mood 
monitoring produce significantly lower attrition rates when compared to studies that do 
not employ those strategies (Linardon & Fuller-Tyszkiewicz (2019; Torous et al., 2020). 
Clearly, we cannot make generalizable conclusions or comparisons regarding 
retention due to the sample size of three participants. Retention rates may continue to be a 
challenge for mobile app research as recent studies report high attrition rates and lower 
levels of engagement with mental health apps (Arean et al., 2016; Pratap et al., 2018). For 
example, Baumel et al. (2019) analyzed data from 93 mental health apps and found that 
90% of users abandoned apps within ten days of installation. Linardon & Fuller-
Tyszkiewicz (2019) conducted a meta-analytic review of randomized controlled trials of 
mHealth interventions and found that the mean percentage of complete protocol 
adherence amongst depression specific apps were 34% and the percentage of participants 
who did not download the app or engage with the app was approximately 41%. Their 
findings also suggest that on average one quarter of participants drop out of trials within 
the first eight weeks and up to one third drop out of trials that require participant for 
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longer than eight weeks. As noted above, our results suggest concerted efforts during 
initial recruitment shows promise in addressing retention issues.  It would be wise for 
larger scale studies to develop multiple ways to engage participants such as user-
instructions (i.e. handouts, YouTube videos) as well as in-person and “remote” check-in 
for additional support. This front-end approach may help participants feel comfortable 
with app, identify and address barriers (e.g. technical issues with app), and increase 
engagement.  
Acceptability 
Acceptability regarding the use of mobile apps was also examined and results 
indicate contradictory results. Specifically, participants indicated they were somewhat to 
very satisfied with the mobile app. Two participants rated that the app was somewhat 
effective at helping them with their depressive symptoms, while one participant indicated 
that it was neither effective nor ineffective. However, all three participants reported they 
would have been able to manage their depressive symptoms slightly better without the 
mobile app. The fact that participants endorsed benefit from the app yet believed they 
would manage symptoms slightly better is an important finding. One possible explanation 
is related to the content validity of this question (How well do you think you would have 
managed your depressive symptoms during these 6 weeks without the mobile 
application?) and that it is not assessing the construct that it was intended to measure of 
perceived effectiveness of the app. Another possible explanation is the first few times 
participants engaged with the app, they found it to be particularly useful as each app 
incorporated a psychoeducational and self-monitoring component. Perhaps, as 
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participants continued to engage with the app, they found it less helpful leading to the 
belief they would have managed their symptoms of depression better without the app.  
Treatment Progress & Outcomes 
The secondary aim was to examine whether participants utilizing a mobile 
application would experience a reduction of depressive symptomology and improvements 
in quality of life. The results indicate that two out of the three participants experienced a 
reduction of depressive symptoms at the post-intervention survey, and the improvement 
remained stable for those two participants at the follow-up survey. Additionally, all three 
participants reported improvements in certain areas of quality of life, such as energy 
level, fatigue, and emotional well-being at the post-intervention survey. These results are 
consistent with previously literature that show mobile app use can reduce depressive 
symptoms (Arean et al., 2016; Firth et al., 2017; Ly et al., 2013; Pratap et al., 2018). Due 
to the small sample size and our inability to use inferential statistics, we are unable to 
firmly state whether these changes were due to their engagement with the mobile apps or 
external factors. The lack of efficacy data is a major problem within mental health app 
research, as the number mental health apps significantly outweighs the available research 
supporting the efficacy of apps as a whole (Neary & Schueller, 2018). Increase research 
and clinical trials along with transparent efficacy data are needed so that healthcare 
providers can recommend evidence-support mental health apps that suite the unique 
mental health needs of the patients they care for.  
Limitations & Future Directions  
The challenges encountered during enrollment of this study provided key insights 
and valuable lessons that could be applied to future research. As previously mentioned, it 
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is vital to establish and maintain a collaborative relationship with the entire primary care 
staff prior to attempting to recruit research participants. In hindsight, one of the biggest 
limitations of this project was the research team not building stronger personal 
connections with the providers prior to implementing the protocol. It may have been 
advantageous to regularly attend the Department of Family Medicine faculty meetings to 
not only introduce the study protocol, purpose, and eligibility criteria, but to also build 
relationships with the providers to address questions, discuss their concerns, and assess 
their interest in collaborating on this project. This would also serve as an opportunity to 
have regular contact with the providers throughout the recruitment process to provide 
recruitment updates, challenges, and reminders, which would be consistent with the 
recommendations of Ash et al. (2000) and Shelton et al. (2002). Future research should 
focus on aspects of feasibility such as patient-flow, provider-time demands, and 
comfortability with mobile apps. Future research on implementation of app-based 
interventions may wish to explore facilitators and barriers within clinical environments 
including timeliness (e.g., implementing within a busy clinical environment) and provider 
knowledge about applications. 
Additionally, research aimed at better understanding acceptability through the use 
of standardized measures is warranted. A limitation of our design is that a threshold for 
acceptability was not predetermined prior to study enrollment. This makes it challenging 
to provide meaningful conclusions regarding acceptability. The heterogeneity of defining 
and assessing acceptability of mental health apps appears to be a common problem within 
the mobile app literature and studies often rely on custom, subjective scales to measure 
satisfaction and acceptability rather than preexisting standardized assessment tools (Ng et 
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al., 2019). In future studies, it will be important to not only provide an operational 
definition of acceptability and satisfaction at the beginning of the study, but to also utilize 
preexisting standardized assessments to evaluate user engagement indicators of mental 
health apps. This will allow comparison of results across studies to better understand 
potential challenges around usability and engagement with mental health apps.  
While this study had high retention rates, we cannot make generalizable 
conclusions or comparisons due to the sample size. It is clear that retention and 
engagement will continue to be a central challenge for mobile app research. As a result, it 
is critical for future studies to further assess factors that may influence adherence, such as 
real-world engagement with apps, digital health literacy, and patient preferences. 
Increased contact with study team members in order to help participants navigate the app 
or provide a reminder to use it may prove effective to increase adherence. This is 
consistent with the research on guided versus unguided self-help interventions, which 
suggests that guided self-help interventions are more effective than unguided 
interventions (Andersson & Cuijpers, 2009; Richards & Richardson, 2012). Additionally, 
future studies may want to explore patient expectations, needs, and attitudes towards 
mHealth apps. A qualitative study of the mindfulness app Headspace found that barriers 
to utilizing the app included difficulty finding time, negative expectations about 
mindfulness, negative experiences using the app, the opinions of other people, and 
uncomfortable emotions (Laurie & Blandford, 2016). Future research efforts in mobile 
apps might consider user end perspectives (e.g., attitudes about mobile apps), research 
methodology (e.g., reminders and in-person meetings with study team members), and 
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real-world factors (e.g., time limitations and barriers). Implementing this type of 
multidimensional approach may aid in reducing issues of retention in mobile health apps.  
Lastly, COVID-19 has resulted in a tremendous increase in the use of digital 
mental health tools within healthcare. The level of engagement and incorporation of 
digital mental health tools will likely continue beyond the COVID-19 pandemic. It is 
vital for future research to ensure that these tools are safe and effective for users. Inkster 
and colleagues (2020) highlight the importance of increasing access to digital healthcare, 
including converting conventional mental health services and resources to mobile apps 
and digital formats, making higher-quality mobiles apps available for free, and creating a 
data repository in order for researchers to understand mobile apps effectiveness across 
socio-cultural demographics. The contributing factors explored in this research regarding 
feasibility and acceptability require additional exploration for population sub-groups to 
address mental health concerns in primary care.  
Conclusion 
This study provides keys insights and important lessons from attempting to 
implement a randomized controlled trial within a primary care setting. Given the results 
of this study and previous literature, the future of mobile app research is contingent upon 
understanding factors that influence user engagement with apps. Addressing the 
aforementioned limitations will shed light on the ways in which user engagement, patient 
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The following questions will ask you about your use and satisfaction with the mobile 
application used during this study. 
 
1. How likely would you be to participate in this study again? 
o Extremely unlikely (1)  
o Somewhat unlikely (2)  
o Neither likely nor unlikely (3)  
o Somewhat likely (4)  
o Extremely likely (5)  
 
2. What did you like most about participating in this study? 
________________________________________________________________ 
 
3. What did you like least about participating in this study? 
________________________________________________________________ 
 
4. What factors might impact your decision to participate again? 
________________________________________________________________ 
 
5. How satisfied are you with the mobile application you worked with? 
o Not at all satisfied (1)  
o Somewhat unsatisfied (2)  
o Neither satisfied nor unsatisfied (3)  
o Somewhat satisfied (4)  
o Very satisfied (5)  
 
6. What specific features of the mobile application did you like the most?  
________________________________________________________________ 
 










8. Would you recommend this mobile application to a friend or family member with 
depression? 
o No, I would not recommend it  
o I am not sure   
o Yes, I would recommend it, with some hesitation 
o Yes, I would strongly recommend it 
 
9. How well do you think you would have managed your depressive symptoms during 
these 6 weeks without the mobile application? 
o Much better (1)  
o Slightly better (2)  
o About the same (3)  
o Slightly worse (4)  
o Much worse (5)  
 
10. How effective was the mobile application at helping you with your depression? 
o Not at all effective (1)  
o Somewhat not effective (2)  
o Neither effective nor ineffective (3)  
o Somewhat effective (4)  
o Very effective (5)  
 
11. How often did you use the skills suggested by the mobile application? 
o Never 
o Once a week 
o 2-3 times a week 
o 4-6 times a week  
o Daily 
 
12. How confident did you feel using the skills that were presented in the mobile app to 
manage depressive symptoms? 
o Very confident (1)  
o Somewhat confident (2)  
o Neither confident or not confident (3)  
o Somewhat not confident (4)  
o Not at all confident (5)  
59 
 
13. Please indicate how confident you are that, over the next three months, you will 
continue to use the mobile application? 
o Extremely likely (1)  
o Moderately likely (2)  
o Slightly likely (3)  
o Neither likely nor unlikely (4)  
o Slightly unlikely (5)  
o Moderately unlikely (6)  
o Extremely unlikely (7)  
 
14. Could you provide any specific comments about the ways in which the mobile 
application helped you manage your depressive symptoms? 
________________________________________________________________ 
 
15. If you were able to add anything to the app to make it more helpful, what might you 
add? (State "nothing" if there is nothing you would add). 
________________________________________________________________ 
 




17. Is there anything else you can tell us about the features, layout, or other design 
aspects of the app that you have found to be either helpful or problematic? (State 






















Health Service Utilization Measure 
The questions below are going to ask you about your use of health care services in the 
past month.  
 
1. In the past month, how many times did you go to a doctor, nurse, or other health 
professional to get care for yourself? 
o None  
o One time  
o Two times  
o Three times  
o Four times 
o Five or more times 
 
2. What was the purpose of the visit? 
________________________________________________________________ 
 
3. In the past month, how many times have you visited your primary care provider at 
Rowan Family Medicine for a health concern? 
o None  
o One time  
o Two times  
o Three times  
o Four times 
o Five or more times 
 
4. What was the purpose of the visit? 
__________________________________________________________ 
 
5. In the past month, have you seen a psychiatrist to discuss and/or receive medications 
for mental health concerns? 





7. In the past month, how many times did you use psychiatric services? 
o None  
o One time  
o Two times  
o Three times  
o Four times 
o Five or more times 
 
8. What was the purpose of the visit? 
________________________________________________________________ 
 
9. In the past month, did you visit the emergency room? 
o Yes 
o No  
 
10. In the past month, how many times did you visit the emergency room? 
o None  
o One time  
o Two times  
o Three times  
o Four times 
o Five or more times 
 





















































Brief Project Description 
The goal of this study is to test the feasibility, acceptability, and preliminary effectiveness of mobile 
applications for depression. Patients will be randomized to one of four conditions: a) a cognitive behavioral 
therapy app, b) a problem-solving therapy app, c) a mindfulness-based app, or d) the waitlist control condition. 
 
We are looking for patients who: 
1) are 18 years of age or older 
2) have a known history of depression AND/OR score between 5 and 14 on the PHQ-9 
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Brief Project Description 
The goal of this study is to test the feasibility, acceptability, and preliminary effectiveness of mobile 
applications for depression. Patients will be randomized to one of four conditions: a) a cognitive behavioral 
therapy app, b) a problem-solving therapy app, c) a mindfulness-based app, or d) the waitlist control condition. 
 
We are looking for patients who: 
1) are 18 years of age or older 
2) have a known history of depression AND/OR score between 5 and 14 on the PHQ-9 
2a) Patients must score a 0 on question 9 of the PHQ-9.  
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If you are at least 18 years old and own an iPhone,  





Study for Adult Patients of Rowan 
Family Medicine with Depression 
We are looking for adults (18 years 
and older) who experience 
depression and are a patient of one 
of the Rowan Family Medicine 
offices to examine whether we can 
use mobile applications to 
effectively treat depressive 
symptoms.  
 
Participants will receive compensation! 
Location 
You only need to meet with a member 
of the research team once! This will 
happen after your appointment with 
your doctor. All other study activity 
will take place online. 
Are you eligible? 
• Are you 18 years old or older? 
• Do you own an iPhone? 
• Are you experiencing symptoms of 
depression? 
If you’re unsure if you meet the 
requirements, email or call the study 
coordinator: 
• Krista Herbert, MA 
• Phone: 609-290-1153 






 Mobile Applications in Primary Care  
Are you a patient of Rowan Family Medicine? Are you experiencing symptoms of 
depression? If you are 18 years old and over and own an iPhone, this study may be for 
you!  
We are conducting a study to assess whether we can use mobile applications to treat 
depression in primary care. Additionally, we want to see if the use of mobile applications 
helps reduce symptoms of depression and improve quality of life. Participation in the 
study is completely voluntary.  
To find out if you are eligible, please click here: 
https://rowan.co1.qualtrics.com/jfe/form/SV_ehw1Lpq0wUbaPzL  
This study has been approved by Rowan Universities IRB #Pro2019000363.  
For additional information or questions, please contact:  
Krista Herbert, MA  
Doctoral Student, Clinical Psychology  
Psychology Department  
Rowan University  
Glassboro, NJ 08028  
herbertk9@rowan.edu 
 
 
